Leerink Swann Reiterates Outperform on VIVUS (VVUS), Review in Health Economics A Positive
Tweet Send to a Friend
Leerink Swann today maintained an Outperform rating on VIVUS, Inc. (Nasdaq: VVUS) with price target of $19 to $20. Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
